Sugi Predict

Sugi Predict / Compounds / SCHEMBL578947

SCHEMBL578947

SCHEMBL578947

O=Cc1cc(OCc2ccccc2)cc(OCc2ccccc2)c1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 9/20 0.75
▸ MAOA P21397 8/20 0.75
▸ MEN1 O00255 1/20 0.59
▸ KMT2A Q03164 1/20 0.59
▸ CCNB2 O95067 1/20 0.58
▸ CDK1 P06493 1/20 0.58
▸ CDK4 P11802 1/20 0.58
▸ CCNB1 P14635 1/20 0.58
▸ CCND1 P24385 1/20 0.58
▸ CCNB3 Q8WWL7 1/20 0.58
▸ CYP1A1 P04798 1/20 0.55
▸ CYP1A2 P05177 1/20 0.55
▸ CYP19A1 P11511 1/20 0.55
▸ RAB9A P51151 2/20 0.54
▸ NPC1 O15118 1/20 0.54
▸ TDP1 Q9NUW8 1/20 0.54
▸ LCK P06239 1/20 0.53
▸ KDM4E B2RXH2 1/20 0.53
▸ ALDH1A1 P00352 1/20 0.53
▸ PKM P14618 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1664699 0.96 MAOA (0.75) MAOBMAOAMEN1KMT2ACCNB2
SCHEMBL5552613 0.92 MAOB (0.65) MAOBMAOAMEN1KMT2ACCNB2
SCHEMBL1748595 0.92 MAOB (0.65) MAOBMAOAMEN1KMT2ACCNB2
SCHEMBL31388310 0.92 MAOB (0.65) MAOBMAOAMEN1KMT2ACCNB2
SCHEMBL1853898 0.91 MAOB (0.69) MAOBMAOAMEN1KMT2ACCNB2
SCHEMBL7145158 0.89 MAOB (0.61) MAOBMAOAMEN1KMT2ACCNB2
SCHEMBL3242914 0.89 MAOB (0.65) MAOBMAOAMEN1KMT2ACCNB2
SCHEMBL16406719 0.89 MAOB (0.65) MAOBMAOAMEN1KMT2ACCNB2
SCHEMBL16990010 0.89 MAOB (0.65) MAOBMAOAMEN1KMT2ACCNB2
SCHEMBL30823523 0.89 MAOB (0.65) MAOBMAOAMEN1KMT2ACCNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10092786-B2 Fire extinguishing composition comprising aldoketones compound XI'AN WESTPEACE FIRE TECHNOLOGY CO., LTD. (CN) 2018-10-09 — — US claimed
US-20160332016-A1 Fire Extinguishing Composition Comprising Aldoketones Compound NANO FIRE, LLC 2016-11-17 — — US claimed
EP-1466884-A1 Process for the preparation of resveratrol and its uses Sochinaz SA (CH) 2004-10-13 — — EP claimed
US-6797745-B1 Hot melt inks containing styrene or terpene polymers XEROX CORPORATION 2004-09-28 — — US claimed
US-6780900-B1 ALDEHYDE COPOLYMER INK VEHICLE, A NONPOLYMERIC ALDEHYDE VISCOSITY MODIFIER, COLORANT, AN OPTIONAL CONDUCTIVITY ENHANCING AGENT, AN OPTIONAL ANTIOXIDANT, AND AN OPTIONAL UV ABSORBER XEROX CORPORATION 2004-08-24 — — US claimed
CN-120842097-A New preparation method of fenoterol 斯坦德药典标准物质研发(湖北)有限公司 2025-10-28 — — CN disclosed
US-20230322654-A1 CANNABINOID DERIVATIVES AND THEIR USE DEMEETRA AGBIO, INC. 2023-10-12 — — US disclosed
US-20230248748-A1 CANNABINOID DERIVATIVES AND THEIR USE DEMEETRA AGBIO, INC. 2023-08-10 — — US disclosed
WO-2023023867-A1 COMPOUNDS FOR REDUCING CHOLESTEROL AND TREATING LIVER AND KIDNEY DISEASE MCMASTER UNIVERSITY (CA) 2023-03-02 — — WO disclosed
US-20230059087-A1 CANNABIDIOL DERIVATIVES, PREPARATION METHOD THEREOF AND USE THEREOF CHENGDU BAIYU PHARMACEUTICAL CO., LTD. (CN) 2023-02-23 — — US disclosed
US-20230059087-A1 CANNABIDIOL DERIVATIVES, PREPARATION METHOD THEREOF AND USE THEREOF CHENGDU BAIYU PHARMACEUTICAL CO., LTD. (CN) 2023-02-23 — — US disclosed
WO-2023015253-A1 CANNABINOID DERIVATIVES AND THEIR USE DEMEETRA AGBIO, INC. (US) 2023-02-09 — — WO disclosed
US-4990505-A Treating asthma, bronchitis; adrenergic stimulants GLAXO GROUP LIMITED (GB) 1991-02-05 — — US disclosed
US-4853382-A TREATING ASTHMA AND BRONCHITIS GLAXO GROUP LIMITED (GB) 1989-08-01 — — US disclosed
EP-0178919-B1 AMINOPHENOL DERIVATIVES GLAXO GROUP LIMITED (GB) 1988-12-21 — — EP disclosed
US-4730008-A STIMULANT FOR BETA-ADRENORECEPTORS GLAXO GROUP LIMITED (GB) 1988-03-08 — — US disclosed
EP-0220878-A2 Ethanolamine compounds GLAXO GROUP LIMITED (GB) 1987-05-06 — — EP disclosed
US-4599327-A NONHABIT-FORMING ANALGESICS CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT (HU) 1986-07-08 — — US disclosed
EP-0178919-A2 Aminophenol derivatives GLAXO GROUP LIMITED (GB) 1986-04-23 — — EP disclosed
US-4054659-A BRONCHODILATORS TANABE SEIYAKU CO., LTD. (JA) 1977-10-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230248748-A1 CANNABINOID DERIVATIVES AND THEIR USE CNR1, CNR2, FAAH MAOB 1277/4885MAOA 1832/4885MEN1 2561/4885
US-20230322654-A1 CANNABINOID DERIVATIVES AND THEIR USE CNR1, CNR2, FAAH MAOB 1277/4885MAOA 1832/4885MEN1 2561/4885
US-20230059087-A1 CANNABIDIOL DERIVATIVES, PREPARATION METHOD THEREOF AND USE THEREOF CNR1, CNR2, UGT2B7 MAOB 970/4885MAOA 1183/4885MEN1 2949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.